Evidence map›Paper›PMID 34480348›Full record

ArticleInternational journal of cancer2022

Impact of the COVID-19 pandemic on population-based cancer registry.

Isabelle Soerjomataram, Aude Bardot, Joanne Aitken, Marion Piñeros, Ariana Znaor, Eva Steliarova-Foucher, Betsy Kohler, Manola Bettio, Tomohiro Matsuda, Marianna de Camargo Cancela and 2 more

Abstract read
In one paragraph

Article in International journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Evaluating the use of new and advanced technologies in a population-based cancer registry.Health information management : journal of the Health Information Management Association of Australia · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Isabelle SoerjomataramCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-6017-741X
Aude BardotCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Joanne AitkenCancer Council Queensland, Brisbane, Queensland, Australia.
Marion PiñerosCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-4249-7276
Ariana ZnaorCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-5849-4782
Eva Steliarova-FoucherCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Betsy KohlerNorth American Association of Central Cancer Registries, Springfield, Illinois, USA.
Manola BettioEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Tomohiro MatsudaDivision of International Collaborative Research, National Cancer Center, Tokyo, Japan.ORCID 0000-0002-7311-1233
Marianna de Camargo CancelaDivision of Surveillance, Instituto Nacional de Cancer (Brazilian National Cancer Institute), Rio de Janeiro, Brazil.
Les MeryCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Freddie BrayCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-3248-7787

Funding

World Health Organization 001
6 · The paper itself

Abstract

The COVID-19 pandemic has caused disruptions to national health systems and impacted health outcomes worldwide. However, the extent to which surveillance systems, such as population-based cancer registration, have been affected was not reported. Here we sought to evaluate the effect of the pandemic on registry operations across different areas and development levels worldwide. We investigated the impact of COVID-19 on three main areas of cancer registry operations: staffing, financing and data collection. An online survey was administered to 750 member registries of the International Association for Cancer Registries. Among 212 responding registries from 90 countries, 65.6% reported a disruption in operations, ranging between 45% in south-eastern Asia and 87% in the Latin America and Caribbean. Active data collection was disrupted more than case notifications or hybrid methods. In countries categorized with low Human Development Index (HDI), a greater number of registries reported a negative impact (81.3%) than in very high HDI countries (57.8%). This contrast was highest in term of impact on financing: 9/16 (56%) registries in low HDI countries reported a current or an expected decline in funding, compared to 7/108 (7%) in very high HDI countries. With many cancer registries worldwide reporting disruption to their operations during the early COVID-19 pandemic, urgent actions are needed to ensure their continuity. Governmental commitment to support future registry operations as an asset to disease control, alongside a move toward electronic reporting systems will help to ensure the sustainability of cancer surveillance worldwide.

Indexed as

COVID-19Global HealthHumansNeoplasmsPandemicsRegistriesSurveys and QuestionnairesCOVID-19 pandemicimpactinternationalpopulation-based cancer registry

Identifiers

PMID34480348
PMCPMC8652711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.